To qualify for this tax credit, the child must: Be your son, daughter, stepchild, eligible foster child, brother, sister, ...

Arsenal missed out on the chance to go eight points clear at the top of the Premier League as they played out a forgettable 0-0 draw with Liverpool. In a match with very little in the way of clear-cut ...

In London, Holly Davies initially thought her Trader Joe’s tote would go unnoticed. The podcast producer snagged the bag for $2.99 at the grocery store on a trip to Washington, D.C. Back in the U.K., ...

When Indiana football head coach Curt Cignetti left the field after the Hoosiers’ first on-site practice ahead of the Rose Bowl game he did so feeling less than satisfied with how things had gone. It ...

SHA shame: Two communities take up almost half county jobs Tears, sorrow as US-based family bids farewell to three siblings killed in road crash ANC interim party leader mulls ending merger with ...

Goldman Sachs upgraded Standard Chartered Plc (SCBFF) to Buy from Neutral on the potential for management to boost its guidance after its 2025 earnings are released or at its investor day in May. The ...

Commerce Secretary Howard Lutnick said Thursday that the U.S. should focus on bringing in immigrants that help expand the economy. His comments come as the White House launches its $1 million Trump ...

Seven large U.S. companies earned Gold Standard parent-friendly status in 2025 for meeting six best practices to support parents in the workplace. Working parents in the U.S. are struggling, fueling ...

Emagine IT has earned authorization as a CMMC Third‑Party Assessment Organization, or C3PAO, reinforcing its role as a trusted provider of Cybersecurity Maturity Model Certification compliance and ...

DES MOINES, Iowa (AP) — Four Republican-led states agreed to settle lawsuits against the federal government over access to voters’ citizenship data, ending a dispute that began with the Biden ...

Apogee Therapeutics, Inc. targets atopic dermatitis with APG777, aiming to outperform Dupixent through less frequent dosing and strong Phase 2 efficacy. APGE's recent $300M fundraising and analyst ...